John Mark Warner
Accountancy in San Diego, CA

License number
Utah 133831-2601
Issued Date
Mar 14, 1980
Expiration Date
Sep 30, 1996
Category
Accountancy
Type
Certified Public Accountant
Address
Address
San Diego, CA
LicenseFiles verified this license of Nov 18, 2016 at the Utah Division of Occupational and Professional Licensing.

Professional information

John Warner Photo 1

Digital Media Creative
Position:
Creative Digital Media Production at Rabid Mind Studios
Location:
San Diego, California
Industry:
Media Production
Work:
Rabid Mind Studios - Greater San Diego Area since Jan 2002 - Creative Digital Media Production Rabid Mind Entertainment - Four Corners : Southwest Colorado Jul 2005 - Sep 2007 - Event Production Web Durango / Durango Herald Feb 2000 - Dec 2002 - Senior Web Developer Directory Plus / Durango Herald Dec 1998 - Feb 2000 - Art Director
Education:
Fort Lewis College 2002 - 2006
BFA, Digital Media
Skills:
Dreamweaver, Photoshop, Flash, Illustrator, PHP, Graphic Design, InDesign, Event Planning, Premiere, Lightroom, Facebook API, Event Photography, Portrait Photography, Audio Engineering, Music Production, Event Coordination, Talent Booking, Project Management, Web Development
Interests:
Graphic Design, Web Development, Photography, Videography, Social Media Marketing, Sound Engineering, Music Production

John Warner Photo 2

Associate Director Of Manufacturing At Sangart Inc.
Position:
Associate Director, Manufacturing at Sangart Inc.
Location:
Greater San Diego Area
Industry:
Biotechnology
Work:
Sangart Inc. since Jan 2011 - Associate Director, Manufacturing Sangart Inc 2005 - Jan 2011 - Sr. Manager, Manufacturing Alliance Pharmaceutical Corporation 1992 - 2001 - Manufacturing Manager

John Warner Photo 3

Director Of Marketing At Us Farms Usa
Position:
Director of Marketing at US Farms USA
Location:
Greater San Diego Area
Industry:
Farming
Work:
US Farms USA - Director of Marketing

John Warner Photo 4

Method For Inhibiting Human Tumor Cells

US Patent:
6410326, Jun 25, 2002
Filed:
Jun 7, 1995
Appl. No.:
08/486683
Inventors:
Harry E. Gruber - San Diego CA
Douglas J. Jolly - La Jolla CA
James G. Respess - San Diego CA
Paul K. Laikind - San Diego CA
Jack R. Barber - San Diego CA
Daniel C. St. Louis - Rockville MD
Sunil D. Chada - Vista CA
Stephen M. W. Chang - San Diego CA
John F. Warner - San Diego CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C12N 1563
US Classification:
435455
Abstract:
Recombinant retroviruses carrying a vector construct capable of preventing, inhibiting, stabilizing or reversing infectious, cancerous or auto-immune diseases are disclosed. More specifically, the recombinant retroviruses of the present invention are useful for (a) stimulating a specific immune response to an antigen or a pathogenic antigen; (b) inhibiting a function of a pathogenic agent, such as a virus; and (c) inhibiting the interaction of an agent with a host cell receptor. In addition, eucaryotic cells infected with, and pharmaceutical compositions containing such a recombinant retrovirus are disclosed. Various methods for producing recombinant retroviruses having unique characteristics, and methods for producing transgenic packaging animals or insects are also disclosed.

John Warner Photo 5

John Warner, San Diego CA
Work:
San Diego

John Warner Photo 6

Method For Making Reflection Defective Retroviral Vectors For Infecting Human Cells

US Patent:
5856185, Jan 5, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/472109
Inventors:
Harry E. Gruber - San Diego CA
Douglas J. Jolly - La Jolla CA
James G. Respess - San Diego CA
Paul K. Laikind - San Diego CA
Jack R. Barber - San Diego CA
Daniel C. St. Louis - Rockville MD
Sunil D. Chada - Vista CA
Stephen M. W. Chang - San Diego CA
John F. Warner - San Diego CA
Assignee:
Chiron Corporation - Emeryville CA
International Classification:
C07H 2104, C12N 510, C12N 1548
US Classification:
435372
Abstract:
Recombinant retroviruses carrying a vector construct capable of preventing, inhibiting, stabilizing or reversing infectious, cancerous or auto-immune diseases are disclosed. More specifically, the recombinant retroviruses of the present invention are useful for (a) stimulating a specific immune response to an antigen or a pathogenic antigen; (b) inhibiting a function of a pathogenic agent, such as a virus; and (c) inhibiting the interaction of an agent with a host cell receptor. In addition, eucaryotic cells infected with, and pharmaceutical compositions containing such a recombinant retrovirus are disclosed. Various methods for producing recombinant retroviruses having unique characteristics, and methods for producing transgenic packaging animals or insects are also disclosed.

John Warner Photo 7

Methods Of Suppressing Immune Response By Gene Therapy

US Patent:
2003009, May 15, 2003
Filed:
Jun 26, 2002
Appl. No.:
10/184007
Inventors:
Jack Barber - San Diego CA, US
John Warner - San Diego CA, US
Michael Irwin - Del Morr CA, US
Thomas Dubensky - San Diego CA, US
Carlos Ibanez - San Diego CA, US
Douglas Jolly - Leucadia CA, US
International Classification:
A61K048/00, C07K014/74
US Classification:
424/093210, 514/044000
Abstract:
Tissue cells of an animal transformed with a multivalent recombinant vector construct are provided. The vector construct expresses a therapeutic protein and either (a) a second protein or active portion thereof capable of inhibiting MHC antigen presentation; (b) an antisense message capable of inhibiting MHC antigen presentation; or (c) a ribozyme capable of inhibiting MHC antigen presentation. Pharmaceutical compositions comprising such multivalent constructs are also provided. The transformed tissue cells are particularly useful within methods for suppressing an immune response.

John Warner Photo 8

Hiv Peptide-Inducted T Cell Stimulation

US Patent:
4943628, Jul 24, 1990
Filed:
Jun 13, 1988
Appl. No.:
7/205983
Inventors:
Jonathan I. Rosen - San Diego CA
John F. Warner - San Diego CA
Assignee:
Ortho Pharmaceutical Corporation - Raritan NJ
International Classification:
C07K 708
US Classification:
530326
Abstract:
The present invention provides peptides derived from HIV-1 which are capable of stimulating T cell proliferation. Such peptides are useful for immunizing human subjects against HIV infection.

John Warner Photo 9

John Warner
Location:
Greater San Diego Area
Industry:
Cosmetics

Accountancy licenses in Utah